In the News

484 News Items found
Pictured: Craig Thompson
Perspective
Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Pictured:  Timothy Chan
In the Lab
Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
A researcher working in an MSK lab
MSK Research Highlights, September 4, 2025
New MSK research shows the Make-an-IMPACT program improves global access to genomic testing in pediatric cancer patients; helped develop an experimental antibody that shows promise against metastatic cancer; sheds light on the origins of ERG-driven prostate cancer; and finds Dupilumab is a successful agent to treat skin toxicities related to antibody-drug conjugates.
iron-filled macrophages from a breast cancer tumor
In the Lab
The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.
Patient on left in chemotherapy infusion chair talking to nurse
Support
Learn about some lesser-known side effects from cancer treatment including falling caused by peripheral neuropathy, fatigue, hormone and sexual changes, and short-term memory problems (chemo brain).
Dr. Lisa DeAngelis
Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
SKI molecular biologist John Maciejowski
A protein in the body that protects against viruses can also cause cancer-related mutations.
An illustration of sugar being sprinkled on a cancer cell.
In the Lab
A study from investigators in the Sloan Kettering Institute uncovers the details of how a key protein called GRP94 becomes disrupted, leading to cancer and other diseases.
Conceptual orange-and-green-colored X-ray showing cancer of the bladder.
In the Clinic
A prominent research grant will enable MSK doctors and scientists to advance the treatment of bladder cancer.
Geneticist Michael Berger
In the Lab
In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations.